The data from these studies will inform the next stages of preclinical research, including Good Laboratory Practice (GLP) enabling studies and future clinical development. While InvestingPro ...
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25. The study will provide safety and ...
The European Medicines Agency and Belgium’s Federal Agency for Medicines and Health Products have approved a Phase 2 challenge study on EV25, an antiviral therapeutic from Eradivir. The approval ...
Eradivir, a preclinical biotech company ... which is broader than the current standard of care. A research paper titled “Targeted recruitment of immune effector cells for rapid eradication of ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
INDIANAPOLIS — GeniPhys, a preclinical-stage company developing regenerative collagen polymeric biomaterials for soft tissue restoration, has been awarded a $500,000 National Science Foundation (NSF) ...